歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗SELENOP多克隆抗體
  • 兔抗SELENOP多克隆抗體

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW20909
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存:90
  • 商品詳情
  • 參考文獻(xiàn)
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品

中文名稱:兔抗SELENOP多克隆抗體   

英文名稱: Anti-SELENOP rabbit polyclonal antibody

別      名: SeP; SELP

相關(guān)類別: 一抗

儲      存: 冷凍(-20℃)

宿      主 Rabbit

抗      原 SELENOP

反應(yīng)種屬 Human

標(biāo)記物: Unconjugate

克隆類型 rabbit polyclonal

技術(shù)規(guī)格

Background:

This gene encodes a selenoprotein that is predominantly expressed in the liver and secreted into the plasma. This selenoprotein is unique in that it contains multiple selenocysteine (Sec) residues per polypeptide (10 in human), and accounts for most of the selenium in plasma. It has been implicated as an extracellular antioxidant, and in the transport of selenium to extra-hepatic tissues via apolipoprotein E receptor-2 (apoER2). Mice lacking this gene exhibit neurological dysfunction, suggesting its importance in normal brain function. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. The mRNA for this selenoprotein contains two SECIS elements. The use of alternative polyadenylation sites, one located in between the two SECIS elements, results in two populations of mRNAs containing either both (predominant) or just the upstream SECIS element (PMID:27881738). Alternatively spliced transcript variants have also been found for this gene.

Applications:

ELISA, IHC

Name of antibody:

SELENOP

Immunogen:

Fusion protein of human SELENOP

Full name:

selenoprotein P

Synonyms:

SeP; SELP; SEPP; SEPP1

SwissProt:

P49908

ELISA Recommended dilution:

2000-5000

IHC positive control:

Human liver cancer and Human breast cancer

IHC Recommend dilution:

25-100